![Glenn C. Rice](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Glenn C. Rice
Fondateur chez
Pacific Biopharma Group
Profil
Glenn C.
Rice was the founder of Convergence Pharmaceuticals, Inc. founded in 1999, serving as President & Chief Executive Officer.
Dr. Rice is the founder of Bridge Pharmaceuticals, Inc. founded in 2004.
Dr. Rice is the founder of Critical Path Institute founded in 2005.
Dr. Rice is the founder of Pacific Biopharma Group founded in 2007.
Dr. Rice is also the founder of EmergingMed.com, Inc...
Former positions include Chief Executive Officer at Pacific Biopharma Group in 2009, Director at CTI BioPharma Corp.
from 1993 to 1998, Director & Vice President-Research at ILEX Oncology, Inc. from 1999 to 2002, Head-Discovery Laboratory at Genentech, Inc. from 1987 to 1993, President & Chief Operating Officer at Pharmacyclics LLC from 2008 to 2010, Vice President-Biosciences at SRI International from 2002 to 2004, and Vice President-Research at Cytokine Networks from 1998 to 1999.
Postes actifs de Glenn C. Rice
| Sociétés | Poste | Début |
|---|---|---|
Pacific Biopharma Group | Fondateur | 03/12/2009 |
Anciens postes connus de Glenn C. Rice
| Sociétés | Poste | Fin |
|---|---|---|
| PHARMACYCLICS, INC. | President | 15/02/2010 |
Pacific Biopharma Group | President | 01/01/2009 |
SRI International
 SRI International Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit scientific research institute and organization | Corporate Officer/Principal | 01/01/2004 |
ILEX Oncology, Inc.
 ILEX Oncology, Inc. BiotechnologyHealth Technology Develops drugs to treat and prevent cancer | Directeur Technique/Scientifique/R&D | 01/01/2002 |
Cytokine Networks | Directeur Technique/Scientifique/R&D | 01/01/1999 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
85
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
CTI BioPharma Corp.
 CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology Engages in acquisition, development and commercialization of novel targeted therapies for blood-related cancers | Health Technology |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology Develops drugs to treat and prevent cancer | Health Technology |
Bridge Pharmaceuticals, Inc.
 Bridge Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research services to the pharmaceutical industry | Commercial Services |
SRI International
SRI International Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit scientific research institute and organization | Commercial Services |
Convergence Pharmaceuticals, Inc.
 Convergence Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat and prevent cancer | Health Technology |
EmergingMed.com, Inc.
 EmergingMed.com, Inc. Medical/Nursing ServicesHealth Services Provides clinical trial, matching and referral services for cancer patients | Health Services |
Critical Path Institute
 Critical Path Institute Miscellaneous Commercial ServicesCommercial Services Provides medical drug and product development review process | Commercial Services |
Cytokine Networks | |
Pacific Biopharma Group |
